↓ Skip to main content

Cost Analysis of the Treatment of Severe Spinal Spasticity With a Continuous Intrathecal Baclofen Infusion System

Overview of attention for article published in PharmacoEconomics, October 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

policy
1 policy source
patent
1 patent

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
89 Mendeley
Title
Cost Analysis of the Treatment of Severe Spinal Spasticity With a Continuous Intrathecal Baclofen Infusion System
Published in
PharmacoEconomics, October 2012
DOI 10.2165/00019053-199915040-00007
Pubmed ID
Authors

Theo Postma, Dettie Oenema, Symon Terpstra, Jelte Bouma, Hannah Kuipers-Upmeijer, Michiel J. Staal, Berry J. Middel

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 1%
Unknown 88 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 15%
Student > Master 13 15%
Other 9 10%
Student > Bachelor 9 10%
Student > Ph. D. Student 8 9%
Other 20 22%
Unknown 17 19%
Readers by discipline Count As %
Medicine and Dentistry 18 20%
Nursing and Health Professions 12 13%
Pharmacology, Toxicology and Pharmaceutical Science 6 7%
Engineering 6 7%
Social Sciences 4 4%
Other 22 25%
Unknown 21 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2014.
All research outputs
#5,446,629
of 25,373,627 outputs
Outputs from PharmacoEconomics
#570
of 1,992 outputs
Outputs of similar age
#39,655
of 191,748 outputs
Outputs of similar age from PharmacoEconomics
#127
of 700 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,992 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,748 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 700 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.